RT Journal Article
SR Electronic
T1 Liver Shape Analysis using Statistical Parametric Maps at Population Scale
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.08.18.22278951
DO 10.1101/2022.08.18.22278951
A1 Thanaj, Marjola
A1 Basty, Nicolas
A1 Cule, Madeleine
A1 Sorokin, Elena P
A1 Whitcher, Brandon
A1 Bell, Jimmy D
A1 Thomas, E Louise
YR 2023
UL http://medrxiv.org/content/early/2023/12/06/2022.08.18.22278951.abstract
AB Background Morphometric image analysis enables the quantification of differences in the shape and size of organs between individuals.Methods Here we have applied morphometric methods to the study of the liver by constructing surface meshes from liver segmentations from abdominal MRI images in 33,434 participants in the UK Biobank. Based on these three dimensional mesh vertices, we evaluated local shape variations and modelled their association with anthropometric, phenotypic and clinical conditions, including liver disease and type-2 diabetes.Results We found that age, body mass index, hepatic fat and iron content, as well as, health traits were significantly associated with regional liver shape and size. Interaction models in groups with specific clinical conditions showed that the presence of type-2 diabetes accelerates age-related changes in the liver, while presence of liver fat further increased shape variations in both type-2 diabetes and liver disease.Conclusions The results suggest that this novel approach may greatly benefit studies aiming at better categorisation of pathologies associated with acute and chronic clinical conditions.Competing Interest StatementMC and EPS are employees of Calico Life Sciences LLCFunding StatementThis research was funded by Calico Life Sciences LLC. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Participant data from the UK Biobank cohort was obtained through UK Biobank Access Application number 44584. The UK Biobank has approval from the North West Multi-Centre Research Ethics Committee (REC reference: 11/NW/0382). All methods were performed in accordance with the relevant guidelines and regulations, and informed consent was obtained from all participants. Researchers may apply to use the UKBB data resource by submitting a health-related research proposal (https://www.ukbiobank.ac.uk).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesResearchers may apply to use the UKBB data resource by submitting a health-related research proposal (https://www.ukbiobank.ac.uk).T2DType 2 DiabetesBMIBody mass indexWHRwaist-to-hip ratioAST:ALTratio of aspartate aminotransferase to alanine aminotransferaseFIB-4Fibrosis-4 indexLiver PDFFLiver percentage density fat fractionMURMass univariate regressionTFCEThreshold-free cluster enhancementSPMsStatistical parametric mapsS2SSurface-to-surface.